Researchers identify over 1,700 dark proteins

Researchers have added a new layer to the human proteome: more than 1,700 previously overlooked protein-like molecules made from stretches of DNA long treated as noncoding. The work, published in Nature by the TransCODE consortium, pushes beyond the standard catalog of roughly 19,500 human proteins and argues that cells are translating many more tiny products than reference databases had captured. EMBL said the team identified these molecules across 7,264 non-canonical open reading frames, or ncORFs, and found evidence that about one quarter of them are translated. That is why some science outlets framed the molecules as “dark proteins,” but the researchers themselves proposed a more specific label: “peptideins.” Jonathan Mudge of EMBL-EBI, a co-first author, said the field had been looking at biology through “an incomplete lens,” and the consortium said the new category is meant to bring these molecules into formal annotation rather than leave them in the proteomic margins. (nature.com) ### Where were these molecules hiding? The newly cataloged molecules came from non-canonical open reading frames — genomic sequences outside the conventional protein-coding regions that many databases historically deprioritized. The TransCODE consortium, which includes EMBL-EBI, the Princess Máxima Center for Pediatric Oncology, the University of Michigan, the Institute for Systems Biology and MIT, searched large-scale proteomics data for evidence that these regions were not just transcribed but translated. (embl.org) Nature’s coverage said thousands of these dark proteins have now been reclassified as peptideins and added as a new category, reflecting a broader effort to separate them from standard proteins without dismissing them as noise. GenomeWeb reported the project characterized more than 3,000 peptides produced by more than 1,700 ncORFs, giving researchers a framework for incorporating them into major proteomics resources. (embl.org) ### Why are researchers treating them as more than statistical leftovers? The consortium said many of the peptideins are very small, which helps explain why earlier protein-mapping methods missed them. EMBL said some were found on immune cell surfaces and may have implications for disease research, including cancer immunotherapy, because cancer cells can express these molecules at high levels. (nature.com) That does not mean each newly listed molecule has a known function. The category includes products whose roles remain uncertain, and the point of the new annotation system is partly to make them easier to test. The consortium said it used CRISPR screens to ask whether some peptideins are essential for cell survival, and it has made the data public to speed follow-up work. (embl.org) ### How does the chirality study fit into this story? A separate study highlighted this week by the Weizmann Institute of Science and the Hebrew University of Jerusalem addresses a different hidden layer of biology: why life favors one mirror-image form of key molecules over the other. In work published in Science Advances, the researchers reported that electrons moving through chiral molecules experience magnetic fields of different strength depending on which mirror-image form they pass through. (embl.org) Ron Naaman of the Weizmann Institute said the key realization was that the difference between the two forms emerges in motion. The institute said that result supports a long-running idea that electron spin and magnetism could help explain biological handedness — the preference for left-handed amino acids and right-handed sugars in living systems. (wis-wander.weizmann.ac.il) ### What happens next for both lines of research? The next step for the dark-proteome work is database integration and functional testing. EMBL said peptideins will be added to GENCODE, UniProt and PeptideAtlas, and the consortium plans to keep releasing data as it is validated. For the chirality study, the immediate milestone is further experimental work on how spin-dependent electron transport could influence chemical selection under prebiotic conditions. (wis-wander.weizmann.ac.il) The Weizmann Institute said the findings were published on May 19, 2026, in Science Advances, giving other groups a defined mechanism to test in origin-of-life experiments. (embl.org)